Search results
FDA Expands Durvalumab Label to Endometrial Cancer
Medscape· 6 days agoThe approval for mismatch repair deficient newly diagnosed advanced or recurrent endometrial cancer was based on improved progression-free survival vs...
US FDA approves Bristol Myers' colorectal cancer therapy
Colorado Springs Gazette· 2 days agoAbout 34% of the patients who were given the combination treatment showed a partial or complete...
Could an FDA-approved cancer drug help stop Parkinson's disease progression?
MedicalNewsToday via AOL· 1 day agoAn existing cancer drug has shown promise in halting Parkinson's disease progression in mouse...
FDA official: The risk of secondary cancer from CAR-T therapy is less than feared
Medical Xpress· 6 days agoThe risk of secondary cancer after CAR-T therapy, pioneered at Penn, is less than regulators feared...
FDA OKs first menthol e-cigarettes, citing potential to help adult smokers | Texarkana Gazette
Texarkana Gazette· 1 day agoThe FDA said it authorized four menthol e-cigarettes from Njoy, the vaping brand recently acquired by tobacco giant Altria, which also...longstanding claim that their products ...
FDA places partial clinical hold on Zentalis’ trials of azenosertib for cancer
Clinical Trials Arena via Yahoo Finance· 4 days ago“We have completed enrolment for Cohort Ib of the DENALI study, where we have enrolled more than 100...
FDA approves menthol vapes, drawing criticism from health advocates
Washington Post· 1 day agoThe Food and Drug Administration on Friday approved the first menthol-flavored e-cigarette products,...
Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold
Zacks via Yahoo Finance· 4 days agoZentalis' (ZNTL) three studies evaluating azenosertib for three different cancer indications face...
FDA sign-off on menthol e-cigarettes ‘flies in the face of public health,’ anti-tobacco groups say
KOMU Columbia· 14 hours agoThe decision drew harsh criticism from pediatricians and anti-tobacco groups, which called it “a blow to public health” and warned of potential for “disastrous consequences” to children. Friday ...
FDA approves MSD’s KEYTRUDA for advanced endometrial cancer
Pharmaceutical Technology via Yahoo Finance· 5 days agoThe latest development comes after MSD signed a definitive agreement to acquire all outstanding...